Work

Enhanced Activity of Hu14.18-IL2 Immunocytokine against Murine NXS2 Neuroblastoma when Combined with Interleukin 2 Therapy

Year: 2004

Type: article

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-03-0799

Authors: Zane C. Neal, Jeannie C. Yang, Alexander L. Rakhmilevich, Ilia N. Buhtoiarov, Hillary E. Lum, Michael Imboden, Jacquelyn A. Hank, Holger N. Lode, Ralph A. Reisfeld, Stephen D. Gillies, Paul M. Sondel

Institutions: University of Wisconsin–Madison, ioGenetics (United States), Humboldt-Universität zu Berlin, Scripps Research Institute

Language: English

Topic: Neuroblastoma Research and Treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G1415676599, G2649204724, Clinical Development of HU14.18-IL2 Targeted Therapy, G665638586, UW Comprehensive Cancer Center Support

OpenAlex ID: W2170379319

FWCI: 3.795

Cites: 39

Cited by: 94

Related to: 10